Rick Randall, TranS1 CEO, attributed the company’s weak report to a higher rate of insurance denials for lumbar surgery due to the medical necessity and ongoing AxiaLF physician reimbursement pressures.
The company reported a net loss of $3.8 million during the third quarter of 2010, a decrease from the reported $4.8 million net loss during the third quarter of 2009.
Read the release on TranS1’s 3Q FY 2010 financial report.
Read more about TranS1:
– TranS1 Releases New System for Lumbar Fusion
– TranS1 Names New President and COO
– TranS1 Names Vice President of Research and Development
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
